SymBio Pharmaceuticals Limited Logo

SymBio Pharmaceuticals Limited

Acquires and commercializes specialty drugs for unmet needs in Japan and the Asia-Pacific region.

4582 | T

Overview

Corporate Details

ISIN(s):
JP3383050006
LEI:
Country:
Japan
Address:
港区虎ノ門四丁目1番28号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

SymBio Pharmaceuticals Limited is a specialty pharmaceutical company dedicated to addressing unmet medical needs. Its core business model involves acquiring the rights to develop and commercialize promising new drug candidates from global bio-ventures and pharmaceutical firms. The company focuses on therapeutic areas including oncology, hematology, autoimmune diseases, and infectious diseases. SymBio aims to deliver innovative treatments to patients, particularly for conditions underserved by the broader industry, with a primary market focus on Japan and the Asia-Pacific region.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-05 02:11
Registration Form
確認書
Japanese 9.0 KB
2025-08-04 09:05
Regulatory News Service
訂正有価証券届出書(参照方式)
Japanese 281.2 KB
2025-08-04 09:04
Interim Report
半期報告書-第21期(2025/01/01-2025/12/31)
Japanese 356.9 KB
2025-07-31 08:37
Registration Form
訂正有価証券届出書(参照方式)
Japanese 276.5 KB
2025-07-22 09:24
Registration Form
有価証券届出書(参照方式)
Japanese 524.8 KB
2025-04-21 03:23
Share Issue/Capital Change
訂正臨時報告書
Japanese 36.1 KB
2025-04-18 09:38
Share Issue/Capital Change
訂正臨時報告書
Japanese 40.4 KB
2025-03-26 05:29
Registration Form
訂正有価証券届出書(参照方式)
Japanese 207.2 KB
2025-03-26 05:04
Post-Annual General Meeting Information
臨時報告書
Japanese 26.2 KB
2025-03-25 07:35
Share Issue/Capital Change
臨時報告書
Japanese 44.1 KB
2025-03-25 07:34
Registration Form
訂正有価証券届出書(参照方式)
Japanese 312.0 KB
2025-03-25 07:32
Governance Information
内部統制報告書-第20期(2024/01/01-2024/12/31)
Japanese 23.9 KB
2025-03-25 07:31
Registration Form
確認書
Japanese 9.0 KB
2025-03-25 07:30
Annual Report
有価証券報告書-第20期(2024/01/01-2024/12/31)
Japanese 1.9 MB
2025-02-20 08:20
Registration Form
訂正有価証券届出書(参照方式)
Japanese 241.9 KB

Automate Your Workflow. Get a real-time feed of all SymBio Pharmaceuticals Limited filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SymBio Pharmaceuticals Limited

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SymBio Pharmaceuticals Limited via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

HELLENIC DYNAMICS PLC Logo
Cultivates and supplies THC-dominant medical cannabis for the European pharmaceutical market.
United Kingdom
HELD
HEMOGENYX PHARMACEUTICALS PLC Logo
Develops CAR-T therapies for blood cancers, autoimmune disorders, and viral infections.
United Kingdom
HEMO
HEM Pharma Inc. Logo
Microbiome biotech using analysis for personalized probiotics, LBPs, and full CDMO services.
South Korea
376270
Hemp Health Spolka Akcyjna Logo
A vertically integrated supplier of medical cannabis raw material for the Polish market.
Poland
HMP
Herantis Pharma Oyj Logo
Developing disease-modifying therapies for neurodegenerative conditions like Parkinson's disease.
Finland
HRTIS
HERON THERAPEUTICS, INC. /DE/ Logo
Develops and commercializes therapies for acute care and oncology to manage pain and nausea.
United States of America
HRTX
Global manufacturer of carbapenem antibiotic APIs for regulated markets.
South Korea
106190
HIKMA Pharmaceuticals PLC Logo
Develops & markets affordable generic & specialty medicines for markets in NA, MENA, & Europe.
United Kingdom
HIK
HISAMITSU PHARMACEUTICAL CO.,INC. Logo
A global leader in transdermal drug delivery systems for OTC and prescription pain relief.
Japan
4530
HLB Genex, Inc. Logo
Develops custom enzymes & microbiome solutions for diagnostics, nutrition, and cosmetic markets.
South Korea
187420

Talk to a Data Expert

Have a question? We'll get back to you promptly.